Enanta Pharma (NASDAQ:ENTA) reported quarterly earnings results on February 09, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.42, beating the consensus estimate of $-0.74 by $0.32 per share. Revenue came in at $18.6M, beating the estimate of $15.4M.
Enanta Pharma's stock moved following the earnings release. The stock currently trades at $14.40 with a market capitalization of $301.9M.